https://www.zacks.com/stock/news/2220349/abbvie-abbv-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2220349
Feb 02, 2024 - The headline numbers for AbbVie (ABBV) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:-1939447443469848350
0
https://www.zacks.com/stock/news/2220350/lyondellbasell-lyb-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2220350
Feb 02, 2024 - While the top- and bottom-line numbers for LyondellBasell (LYB) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:-8010642846492766149
0
https://www.zacks.com/stock/news/2220247/compared-to-estimates-firstcash-fcfs-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2220247
Feb 02, 2024 - While the top- and bottom-line numbers for FirstCash (FCFS) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:1517650944536418676
0
https://www.zacks.com/stock/news/2220248/church-dwight-chd-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2220248
Feb 02, 2024 - While the top- and bottom-line numbers for Church & Dwight (CHD) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:-5507496528427053556
0
https://www.zacks.com/stock/news/2220253/m-a-com-mtsi-reports-q1-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2220253
Feb 02, 2024 - Although the revenue and EPS for M/A-Com (MTSI) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:-5600903174165508478
0
https://www.zacks.com/stock/news/2220251/regeneron-regn-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2220251
Feb 02, 2024 - Although the revenue and EPS for Regeneron (REGN) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:-54377411717849244
0
https://www.zacks.com/stock/news/2220252/aon-aon-q4-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2220252
Feb 02, 2024 - Although the revenue and EPS for Aon (AON) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:7596684386296815385
0
https://www.zacks.com/stock/news/2220250/compared-to-estimates-bristol-myers-bmy-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2220250
Feb 02, 2024 - While the top- and bottom-line numbers for Bristol Myers (BMY) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:-4652221411308788484
0
https://www.zacks.com/stock/news/2220249/compared-to-estimates-cigna-ci-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2220249
Feb 02, 2024 - While the top- and bottom-line numbers for Cigna (CI) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:-6136342845322493243
0
https://www.zacks.com/stock/news/2220254/here-s-what-key-metrics-tell-us-about-dolby-laboratories-dlb-q1-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2220254
Feb 02, 2024 - Although the revenue and EPS for Dolby Laboratories (DLB) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:-3605296074399067809
0